Monopar Therapeutics Inc. (MNPR) vs YD Bio Limited (YDES)

Monopar Therapeutics Inc. MNPR 69.27 −3.52%
YD Bio Limited YDES 5.92 −12.17%

Monopar Therapeutics Inc. and YD Bio Limited are both Biotechnology companies. Monopar Therapeutics Inc. and YD Bio Limited are of similar size ($481.9M and $477.5M).

Metric	MNPR	YDES	Biotechnology median
P/E	n/m	—	8.50
P/S	n/m	—	9.71
P/B	4.52	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	n/m	—	9.21
Earnings yield	(3.13%)	—	(33.15%)
Free cash flow yield	(2.06%)	—	(25.50%)

Metric	MNPR	YDES	Biotechnology median
Gross margin	—	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(19.50%)	—	(56.36%)
Return on assets	(18.90%)	—	(48.04%)
Return on invested capital	0.00%	—	0.00%

Metric	MNPR	YDES	Biotechnology median
Revenue growth (TTM)	—	—	6.02%
EPS growth (last fiscal year)	54.99%	—	30.26%
Revenue growth, 5-year CAGR	—	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	MNPR	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	33.56	—	4.72
Net debt to EBITDA	8.06	—	0.96

Metric	MNPR	YDES	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	MNPR	YDES	Biotechnology median
Market cap	481.93m	477.48m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack